HALO logo
halo search icon
Oramed Pharmaceuticals Incorporated
Oramed Pharmaceuticals Incorporated
ORMP · NAS

Oramed Pharmaceuticals Incorporated

US$4.28

Price Arrow-0.05 (-1.155%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Price MomentumHammer BearishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Oramed Pharmaceuticals Incorporated Overview

ORMP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ORMP

icon

Telephone

1.844.967.2633

icon

Address

Third floor, 1185 Avenue of the Americas, New York, NY 10036

Description

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

ORMP Price Chart

Key Stats

Market Cap

US$175.13M

PE

1.90

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

N/A

Ex Dividend Date (est.)

16-Jan-26

Market Data

52 weeks range

Low 1.98 - 5.01

Trade Value (12mth)

US$112,575.00

1 week

-6.68%

1 month

12.47%

YTD

48.8%

1 year

105.21%

All time high

31.73

Key Fundamentals

EPS 3 yr Growth

-262.90%

EBITDA Margin

-748.30%

Operating Cashflow

-$9m

Free Cash Flow Return

-5.30%

ROIC

36.50%

Interest Coverage

0.00

Quick Ratio

7.00

Other Data

Shares Outstanding (Fully Diluted)

40m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

16-Jan-26

Next Dividend Pay Date

26-Jan-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

ORMP Announcements

Latest Announcements

DateAnnouncements
20 May 26
01 April 26
27 March 26
21 February 26
21 February 26

ORMP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.14-0.471.53locklocklock
EPS (Fully Diluted)
$locklocklocklock0.14-0.471.5locklocklock
Growth
%locklocklocklock114.6-440.7427.2locklocklock
PE
Xlocklocklocklock16.9N/A1.9locklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

16-Jan-26

DIV Yield

0%

Franking Level

N/A

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Oramed Pharmaceuticals Incorporated (ORMP:NAS)?
Halo FAQ
The current share price of Oramed Pharmaceuticals Incorporated (ORMP:NAS) is USD$4.28.
What is the 52-week high share price for Oramed Pharmaceuticals Incorporated (ORMP:NAS)?
Halo FAQ
The 52-week high share price for Oramed Pharmaceuticals Incorporated (ORMP:NAS) is USD$5.01.
What is the 52-week low share price for Oramed Pharmaceuticals Incorporated (ORMP:NAS)?
Halo FAQ
The 52-week low share price for Oramed Pharmaceuticals Incorporated (ORMP:NAS) is USD$1.98.
What is the dividend yield for Oramed Pharmaceuticals Incorporated (ORMP:NAS)?
Halo FAQ
Oramed Pharmaceuticals Incorporated (ORMP:NAS) does not pay a dividend.
What was Oramed Pharmaceuticals Incorporated (ORMP:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Oramed Pharmaceuticals Incorporated (ORMP:NAS) is USD$0.25.
What is the franking level for Oramed Pharmaceuticals Incorporated (ORMP:NAS)?
Halo FAQ
Oramed Pharmaceuticals Incorporated (ORMP:NAS) has a franking level of 0.00%.
In which sector is Oramed Pharmaceuticals Incorporated (ORMP:NAS) classified?
Halo FAQ
Oramed Pharmaceuticals Incorporated (ORMP:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Oramed Pharmaceuticals Incorporated (ORMP:NAS)?
Halo FAQ
The current P/E ratio for Oramed Pharmaceuticals Incorporated (ORMP:NAS) is 1.90.

See beyond the curve.

One solution for research, investing and portfolio management.